🇸🇪 IPercept raises $16.5 million Series A to scale CNC machine monitoring in the US and Europe

September 29, 2026
IPercept has raised a $16.5 million Series A to redefine CNC-specialized industrial service in Europe and in the USA. The round was co-led by Isogon Ventures and 2150, and existing investors Luminar Ventures, RunwayFBU, J12 Ventures and AI.Fund all participated.
IPercept’s patented technology enables CNC machine tools to report their own mechanical condition. With this funding, the company will scale its operations in the US, grow its partnerships with industrial service providers and extend its data platform with a series of add-on intelligence applications.
Technology and impact
CNC machine tools are the precision systems that manufacture the components underpinning modern life, from aircraft engines and medical implants to cars, electronics and energy infrastructure. The installed base is worth roughly $1 trillion worldwide, and the machines feed huge industries including automotive, aerospace, electronics, medical devices, machinery, energy and defence.
CNC machines are also the least observed asset in the factory. The machine controller commands motion but does not measure mechanical condition. Vibration sensors were designed for pumps and motors, not for machines with dozens of interacting components. This blind spot has existed since the 1940s, and without IPercept’s technology, it still takes two days of manual work to fully understand why a single machine failed, and average machine efficiency has been stuck at 50–60% for decades.
IPercept reads the machine’s own motion. A single patented IPercept device, mounted on the moving part of a CNC machine of any brand, model or age, converts micrometre-scale motion into component-level condition data. It has no connection to the machine controller or the customer’s IT network. Production and maintenance teams see which components are wearing, such as spindles, ballscrews, guides and bearings, how quickly, and exactly what to do before production stops.
Use of funding
IPercept will expand operations in the US and make its first dedicated local hires in sales and deployment. The company will add a series of add-on intelligence applications to its data platform and scale its partnerships with industrial service providers while growing its engineering and data science teams.
Company background
“CNC machine tools make every other machine on Earth, and until now almost nobody could see inside them on component-level while they run. That took a new measurement principle, five years of research, and four years of real-world data. We are ready to bring it to every factory that needs it,” said Karoly Szipka, Founder and CEO of IPercept.
Szipka holds a PhD in CNC machine diagnostics from KTH Royal Institute of Technology, and co-founder Andreas Archenti is a chair professor in industrial dependability at KTH.
Contact
IPercept
Drottning Kristinas Väg 53
114 28 Stockholm, Sweden
+46 73 020 98 58
For more information, visit IPercept.
Originally published on September 29, 2026 by IPercept.
Announcements for publication can be submitted to [email protected]